Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
nimotuzumab (2 trials)
Glioblastoma (Phase 3)
Pancreatic Neoplasms (Phase 3)
Trials (2 total)
Trial APIs (1 total)